In addition, germline variants that predispose to cancer may provide prognostic value and inform on treatment options, as we demonstrated in one of our cases (P0013) with the identification of a BRCA1 germline mutation that led to our recommendation for cisplatin chemotherapy. This evidence concerns the gene BRCA1 and cancer.